ISRCTN65588717已完成未知
Implantation Of Biofreedom® drug-coated stents with very short dual antiplatelet therapy In patients at high bleeding risk: real-world data
niversity Hospital of Muenster0 个研究点目标入组 89 人开始时间: 2018年12月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 89
研究概览
简要总结
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/31965195/ (added 27/09/2021)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Implantation of at least one Biofreedom® stent for the treatment of significant CAD during the study period
- •2. At least one criterion for high risk bleeding
排除标准
- •1. Aged <18 years
- •2. Current pregnancy
- •3. Underlying malignant disease
- •4. Active bleeding
- •5. Unable to give informed consent
研究者
相似试验
终止
不适用
Biofreedom Prospective Multicenter Observational RegistryCoronary Artery Disease AggravatedMyocardial InfarctionMyocardial IschemiaNCT03045848Wonju Severance Christian Hospital194
Unknown
不适用
A Randomized Clinical Evaluation of the BioFreedom™ StentIschemic Heart Disease SilentST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial InfarctionIn-stent Coronary Artery RestenosisBleedingStable AnginaNCT01623180Biosensors Europe SA2,456
已完成
不适用
Biofreedom Stent in All Comer PopulationCoronary Artery DiseaseNCT02858739University of Roma La Sapienza1,000
已完成
2 期
Phase 2 study of biodegradable stents (BD-stent) for refractory benign esophageal strictures after curative treatment of esophageal cancerJPRN-UMIN000008054ational Cancer Center Hospital East20
已完成
不适用
Angiographic and IVUS Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)Percutaneous Coronary AngioplastyNCT01382043Liuhuaqiao Hospital48